Literature DB >> 8200971

Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation.

R Roubenoff1, R A Roubenoff, J G Cannon, J J Kehayias, H Zhuang, B Dawson-Hughes, C A Dinarello, I H Rosenberg.   

Abstract

The cytokines IL-1 beta and TNF-alpha cause cachexia and hypermetabolism in animal models, but their role in human inflammation remains controversial. The relationship between in vitro cytokine production and metabolism was examined in 23 adults with RA and 23 healthy control subjects matched on age, sex, race, and weight. Body composition was measured by multicompartmental analysis of body cell mass, water, fat, and bone mass. Resting energy expenditure (REE) was measured by indirect calorimetry. Cytokine production by PBMC was measured by radioimmunoassay. Usual energy intake, physical activity, disability scores, medication use, and other confounders were also measured. Body cell mass was 13% lower (P < 0.00001), REE was 12% higher (P < 0.008), and physical activity was much lower (P < 0.001) in subjects with RA. Production of TNF-alpha was higher in RA than controls, both before and after stimulation with endotoxin (P < 0.05), while production of IL-1 beta was higher with endotoxin stimulation (P < 0.01). In multivariate analysis, cytokine production was directly associated with REE (P < 0.001) in patients but not in controls. While energy and protein intake were similar in the two groups and exceeded the Recommended Dietary Allowances, energy intake in subjects with RA was inversely associated with IL-1 beta production (P < 0.005). In this study we conclude that: loss of body cell mass is common in RA; cytokine production in RA is associated with altered energy metabolism and intake, despite a theoretically adequate diet; and TNF-alpha and IL-1 beta modulate energy metabolism and body composition in RA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200971      PMCID: PMC294444          DOI: 10.1172/JCI117244

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Enteral hyperalimentation: an alternative to central venous hyperalimentation.

Authors:  S B Heymsfield; R A Bethel; J D Ansley; D W Nixon; D Rudman
Journal:  Ann Intern Med       Date:  1979-01       Impact factor: 25.391

Review 2.  Starvation in man.

Authors:  G F Cahill
Journal:  N Engl J Med       Date:  1970-03-19       Impact factor: 91.245

3.  Energy and the maintenance of the body cell mass.

Authors:  F D Moore
Journal:  JPEN J Parenter Enteral Nutr       Date:  1980 May-Jun       Impact factor: 4.016

4.  Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production.

Authors:  D S Snyder; E R Unanue
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

5.  Comparison of methods of estimating body fat in normal subjects and cancer patients.

Authors:  S H Cohn; K J Ellis; D Vartsky; A Sawitsky; W Gartenhaus; S Yasumura; A N Vaswani
Journal:  Am J Clin Nutr       Date:  1981-12       Impact factor: 7.045

6.  The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales.

Authors:  J F Fries; P W Spitz; D Y Young
Journal:  J Rheumatol       Date:  1982 Sep-Oct       Impact factor: 4.666

7.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Authors:  W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

Review 8.  The role of cytokines in cancer cachexia.

Authors:  L L Moldawer; M A Rogy; S F Lowry
Journal:  JPEN J Parenter Enteral Nutr       Date:  1992 Nov-Dec       Impact factor: 4.016

9.  Body composition measurements in normal man: the potassium, sodium, sulfate and tritium spaces in 58 adults.

Authors:  R N Pierson; J Wang; E W Colt; P Neumann
Journal:  J Chronic Dis       Date:  1982

10.  Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment.

Authors:  D M Reid; N S Kennedy; M A Smith; P Tothill; G Nuki
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-31
View more
  125 in total

Review 1.  [Pathophysiology of catabolism in undernurished elderly patients].

Authors:  D Baez-Franceschi; J E Morley
Journal:  Z Gerontol Geriatr       Date:  1999-07       Impact factor: 1.281

Review 2.  [Causes of protein-calorie malnutrition].

Authors:  D R Thomas
Journal:  Z Gerontol Geriatr       Date:  1999-07       Impact factor: 1.281

3.  Intermuscular adipose tissue and metabolic associations in HIV infection.

Authors:  Rebecca Scherzer; Wei Shen; Steven B Heymsfield; Cora E Lewis; Donald P Kotler; Mark Punyanitya; Peter Bacchetti; Michael G Shlipak; Carl Grunfeld
Journal:  Obesity (Silver Spring)       Date:  2010-06-10       Impact factor: 5.002

Review 4.  [Physical therapy as part of a complex orthopedic rheumatology approach. Physiotherapy, cryotherapy, extracorporeal shockwave lithotripsy, local intra-articular joint injections].

Authors:  I Arnold; T Guttke
Journal:  Orthopade       Date:  2012-07       Impact factor: 1.087

5.  Body composition abnormalities in long-term survivors of pediatric hematopoietic stem cell transplantation.

Authors:  Sogol Mostoufi-Moab; Jill P Ginsberg; Nancy Bunin; Babette S Zemel; Justine Shults; Meena Thayu; Mary B Leonard
Journal:  J Pediatr       Date:  2011-08-11       Impact factor: 4.406

Review 6.  Rheumatoid cachexia and cardiovascular disease.

Authors:  Gregory D Summers; Giorgos S Metsios; Antonios Stavropoulos-Kalinoglou; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2010-07-20       Impact factor: 20.543

7.  Protective effects of indomethacin and cyclophosphamide but not of infliximab on liver metabolic changes caused by adjuvant-induced arthritis.

Authors:  Maria Angélica Raffaini Covas Pereira da Silva; Ciomar Aparecida Bersani-Amado; Emy Luiza Ishii-Iwamoto; Lívia Bracht; Silvana Martins Caparroz-Assef
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

8.  Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.

Authors:  Inge A M van den Oever; Alper M van Sijl; Michael T Nurmohamed
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-08       Impact factor: 5.346

Review 9.  Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation.

Authors:  Kevin G Burfeind; Vijayshree Yadav; Daniel L Marks
Journal:  Curr Neurol Neurosci Rep       Date:  2016-11       Impact factor: 5.081

Review 10.  Anorexia in older persons: epidemiology and optimal treatment.

Authors:  J E Morley
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.